
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias. Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.
SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF) (“Cardiff Oncology” or the “Company”), a clinical-stage biotechnology company leveraging PLK1 inhibition to...
- Initial results from randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care in RAS-mut mCRC demonstrated 64% ORR in the 30mg onvansertib dose arm versus 33% ORR in the...
- Protects the use of onvansertib in combination with standard of care in the KRAS mutated mCRC setting through 2043 - SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc...
- Published positive Phase 2 trial results of onvansertib in combination with FOLFIRI and bev in second-line KRAS mutant mCRC in the peer-reviewed Journal of Clinical Oncology - - Initial data...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.1501 | 33.0488505747 | 3.48 | 4.8299 | 3.46 | 1069497 | 4.16235999 | CS |
4 | 0.7201 | 18.4168797954 | 3.91 | 4.8299 | 3.25 | 977843 | 3.6860501 | CS |
12 | 1.6501 | 55.3724832215 | 2.98 | 5.6395 | 2.26 | 2176526 | 3.8135907 | CS |
26 | 2.5401 | 121.535885167 | 2.09 | 5.6395 | 2.06 | 1324802 | 3.5407463 | CS |
52 | 3.1301 | 208.673333333 | 1.5 | 6.42 | 1.47 | 1282137 | 3.5836498 | CS |
156 | 1.3401 | 40.7325227964 | 3.29 | 6.42 | 0.94 | 770950 | 2.84391145 | CS |
260 | 2.7401 | 144.978835979 | 1.89 | 25.5 | 0.701 | 908580 | 5.87800123 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions